Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Swedish Orphan Biovitrum AB

+ Add to Watchlist

SOBI:SS

93.2000 SEK 1.3000 1.38%

As of 11:30:00 ET on 03/06/2015.

Snapshot for Swedish Orphan Biovitrum AB (SOBI)

Open: 94.5500 Day's Range: 92.8500 - 95.0000 Volume: 958,793
Previous Close: 94.5000 52wk Range: 65.0000 - 95.8500 1-Yr Rtn: +11.48%

Stock Chart for SOBI

No chart data available.
  • SOBI:SS 93.2000
  • 1D
  • 1M
  • 1Y
94.5000
Interactive SOBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SOBI

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 102.9834
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -0.9900
Est. EPS (SEK) (12/2015) 0.9050
Est. PEG Ratio -
Market Cap (M SEK) 25,681.53
Shares Outstanding (M) 270.39
30 Day Average Volume 746,516
Price/Book (mrq) 5.4878
Price/Sale (ttm) 9.5160
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SOBI

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for SOBI

Swedish Orphan Biovitrum AB is a biomedical company. The Company develops and makes available orphan drugs and niche specialty pharmaceuticals for patients with rare diseases and with high unmet medical needs.

Geoffrey McDonoughPresident/CEOMats-Olof WallinSenior VP/CFO
Alan RaffenspergerSenior VP/COOBirgitte VolckSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for SOBI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil